acetylcysteine has been researched along with tamoxifen in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Han, XL; Liehr, JG | 1 |
| Arnstein, HR; Cannon, M; Wiseman, H | 1 |
| Sharma, M; Slocum, HK | 1 |
| Dietrich, W; Huber, JC; Kolbus, A; Stonek, F; Tschugguel, W; Zhegu, Z | 1 |
| Chang, T; Hayes, EC; Mitra, SW; Peekhaus, NT; Rohrer, SP; Schaeffer, JM; Wilkinson, HA | 1 |
| Corbet, C; Heldt, JM; Jaouen, G; Jouy, N; Laïos, I; Leclercq, G; Lories, N; Toillon, RA; Vessières, A | 1 |
| Kaufmann, Y; Klimberg, VS; Luo, S; Todorova, VK | 1 |
| Dan, S; Guo, WZ; Ohashi, Y; Shiina, I; Uetake, S; Umeda, E; Wang, Y; Watanabe, C; Yamori, T | 1 |
| Amarell, S; Cheng, Z; Linarelli, LE; Liu, D; Liu, L; Passaro, A; Zheng, L; Zou, P | 1 |
| Ignatov, A; Kalinski, T; Nass, N; Roessner, A; Sel, S | 1 |
| Cao, P; Gong, X; Lin, Y; Liu, L; Luo, M; Wu, T; Yang, Q; Zhou, L | 1 |
1 review(s) available for acetylcysteine and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for acetylcysteine and tamoxifen
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Induction of covalent DNA adducts in rodents by tamoxifen.
Topics: Acetylcysteine; Animals; Ascorbic Acid; Cricetinae; DNA; Female; Kidney; Liver; Premedication; Rats; Rats, Inbred Strains; Tamoxifen | 1992 |
Protection by glutathione against one component of the bimodal inhibition of growth by tamoxifen in Saccharomyces cerevisiae.
Topics: Acetylcysteine; Ascorbic Acid; Breast Neoplasms; Cell Division; Glutathione; Humans; Saccharomyces cerevisiae; Tamoxifen; Tumor Cells, Cultured | 1990 |
Prevention of quinone-mediated DNA arylation by antioxidants.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Chromatography, High Pressure Liquid; Diethylstilbestrol; DNA Adducts; Horseradish Peroxidase; Hydrogen Peroxide; Male; Salmon; Tamoxifen; Testis | 1999 |
Differential regulation of proteasome-dependent estrogen receptor alpha and beta turnover in cultured human uterine artery endothelial cells.
Topics: Acetylcysteine; Adenosine Triphosphate; Antibody Specificity; Arteries; Blotting, Western; Cell Nucleus; Cell-Free System; Cells, Cultured; Cycloheximide; Cysteine Endopeptidases; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation; Humans; Insulin; Kinetics; Multienzyme Complexes; Proteasome Endopeptidase Complex; Puromycin; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Uterus | 2003 |
Distinct effects of the antiestrogen Faslodex on the stability of estrogen receptors-alpha and -beta in the breast cancer cell line MCF-7.
Topics: Acetylcysteine; Animals; Breast Neoplasms; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression Regulation; Genes, Reporter; Humans; Ligands; Point Mutation; Tamoxifen | 2004 |
A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines.
Topics: Acetylcysteine; Antioxidants; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cellular Senescence; Female; Ferrous Compounds; Humans; Reactive Oxygen Species; Receptors, Estrogen; Tamoxifen | 2010 |
Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.
Topics: Acetylcysteine; Amino Acid Transport System ASC; Antioxidants; Apoptosis; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Estradiol; Female; Gene Expression; Glutamine; Glutathione; Humans; Minor Histocompatibility Antigens; Oxidative Stress; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen | 2011 |
Ridaifen-SB8, a novel tamoxifen derivative, induces apoptosis via reactive oxygen species-dependent signaling pathway.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Apoptosis Inducing Factor; Caspases; Cell Line, Tumor; Estrogen Receptor alpha; Free Radical Scavengers; Gene Knockdown Techniques; Gliosarcoma; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Protein Transport; Reactive Oxygen Species; Signal Transduction; Tamoxifen | 2013 |
Tamoxifen reduces fat mass by boosting reactive oxygen species.
Topics: Acetylcysteine; Adipocytes; Adipose Tissue; Adiposity; Animals; Antioxidants; Apoptosis; Autophagy; Cell Count; Down-Regulation; Forkhead Box Protein O1; Forkhead Transcription Factors; Male; Mice; Oxidative Stress; PPAR gamma; Reactive Oxygen Species; Tamoxifen | 2015 |
Oxidative stress and glyoxalase I activity mediate dicarbonyl toxicity in MCF-7 mamma carcinoma cells and a tamoxifen resistant derivative.
Topics: Acetylcysteine; Aldehydes; Drug Resistance, Neoplasm; Humans; Lactoylglutathione Lyase; MAP Kinase Signaling System; MCF-7 Cells; Oxidative Stress; Reactive Oxygen Species; Tamoxifen | 2016 |
Tamoxifen Prevents D-galactosamine/Lipopolysaccharide-Induced Murine Acute Hepatic Failure through Inhibition of Oxidative Stress and Mmd-2 Upregulation.
Topics: Acetylcysteine; Alanine Transaminase; Animals; Antigens, Differentiation; Antioxidants; Aspartate Aminotransferases; Catalase; Galactosamine; Glutathione Peroxidase; Lipopolysaccharides; Liver Failure, Acute; Mice; Mice, Inbred BALB C; Oxidative Stress; Superoxide Dismutase; Tamoxifen; Up-Regulation | 2018 |